This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Raw Turtle (+ also see Turtle/RDF Format Specification)
Drug-drug interaction between prescription and medication statement
@prefix fhir: <http://hl7.org/fhir/> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- [a fhir:DetectedIssue ; fhir:nodeRole fhir:treeRoot ; fhir:id [ fhir:v "ddi"] ; # fhir:text [ fhir:status [ fhir:v "generated" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <p><b>Severity: High</b> - Risk of internal bleeding</p>\n <p>Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding.</p>\n <ul>\n <li><a href=\"MedicationStatement/tylenol\">500 mg Acetaminophen tablet 1/day, PRN since 2010</a></li>\n <li><a href=\"MedicationRequest/warfarin\">Warfarin 1 MG TAB prescribed Jan. 5, 2014</a></li>\n </ul>\n <p>Mitigation: Jan 5, 2014 by Dr. Adam Careful: </p>\n <p>Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring</p>\n </div>" ] ; # fhir:status [ fhir:v "final"] ; # fhir:category ( [ fhir:coding ( [ fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/v3-ActCode"^^xsd:anyURI ] ; fhir:code [ fhir:v "DRG" ] ; fhir:display [ fhir:v "Drug Interaction Alert" ] ] ) ] ) ; # fhir:code [ fhir:coding ( [ fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/v3-ActCode"^^xsd:anyURI ] ; fhir:code [ fhir:v "DRG" ] ; fhir:display [ fhir:v "Drug Interaction Alert" ] ] ) ] ; # fhir:severity [ fhir:v "high"] ; # fhir:subject [ fhir:reference [ fhir:v "Device/example" ] ] ; # fhir:identified [ fhir:v "2014年01月05日"^^xsd:date] ; # fhir:implicated ( [ fhir:reference [ fhir:v "MedicationStatement/example001" ] ; fhir:display [ fhir:v "500 mg Acetaminophen tablet 1/day, PRN since 2010" ] ] [ fhir:reference [ fhir:v "MedicationRequest/medrx0331" ] ; fhir:display [ fhir:v "Warfarin 1 MG TAB prescribed Jan. 15, 2015" ] ] ) ; # fhir:detail [ fhir:v "Risk of internal bleeding. Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding."] ; # fhir:mitigation ( [ fhir:action [ fhir:coding ( [ fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/v3-ActCode"^^xsd:anyURI ] ; fhir:code [ fhir:v "13" ] ; fhir:display [ fhir:v "Stopped Concurrent Therapy" ] ] ) ; fhir:text [ fhir:v "Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring" ] ] ; fhir:date [ fhir:v "2014年01月05日"^^xsd:date ] ; fhir:author [ fhir:reference [ fhir:v "Practitioner/example" ] ; fhir:display [ fhir:v "Dr. Adam Careful" ] ] ] )] . # # -------------------------------------------------------------------------------------
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.